Big Pharma is still relying on belt-tightening to prop up financial results. Pfizer Inc and Merck & Co said on Tuesday their quarterly results were again hit by generic competition for once top-selling ...
via Business News http://finance.yahoo.com/news/cost-controls-help-pfizer-merck-201003645.html
0 commentaires:
Enregistrer un commentaire